1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Ildong Pharmaceutical Co., Ltd.
  6. Financials
    A249420   KR7249420001

ILDONG PHARMACEUTICAL CO., LTD.

(A249420)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Valuation
Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization1 372 966505 258463 622379 499449 542799 187
Enterprise Value (EV)1 483 401595 354516 389454 862530 235870 661
P/E ratio 11,2x24,2x36,5x-28,2x-34,6x-8,02x
Yield 1,58%-1,96%---
Capitalization / Revenue 1,85x1,10x0,92x0,73x0,80x1,43x
EV / Revenue 2,40x1,29x1,02x0,88x0,94x1,55x
EV / EBITDA 21,7x13,6x10,2x17,2x16,0x-34,7x
Price to Book 1,26x1,61x1,59x1,50x1,77x5,23x
Nbr of stocks (in thousands) 23 80623 80523 80523 79023 78523 785
Reference price (KRW) 15 66721 22419 47615 95218 90033 600
Announcement Date 03/16/201703/14/201903/12/202003/18/202103/17/202203/17/2022
1 KRW in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales1 201 344460 651503 907517 468561 845560 132
EBITDA1 22 29143 80750 75526 37633 192-25 101
Operating profit (EBIT)1 14 79225 36127 155-1 5425 529-54 412
Operating Margin 7,35%5,51%5,39%-0,30%0,98%-9,71%
Pre-Tax Profit (EBT)1 14 01420 42216 438-22 634-9 724-141 205
Net income1 12 57919 84112 721-13 444-13 019-99 705
Net margin 6,25%4,31%2,52%-2,60%-2,32%-17,8%
EPS2 1 395876534-565-547-4 192
Dividend per Share2 247-381---
Announcement Date 03/16/201703/14/201903/12/202003/18/202103/17/202203/17/2022
1 KRW in Million
2 KRW
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2019 Q4 2020 Q1 2020 Q2
Net sales1 122139137
EBITDA1 -5,5914,2
Operating profit (EBIT)1 -7,54-1,297,22
Operating Margin -6,17%-0,93%5,26%
Pre-Tax Profit (EBT) ---
Net income ---
Net margin ---
EPS ---
Dividend per Share ---
Announcement Date 02/14/202005/07/202008/13/2020
1 KRW in Billions
Balance Sheet Analysis
Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt1 110 43590 09652 76875 36280 69271 474
Net Cash position1 ------
Leverage (Debt / EBITDA) 4,95x2,06x1,04x2,86x2,43x-2,85x
Free Cash Flow -17 86346 32228 990-1 447101 154
ROE (Net Profit / Equities) -7,18%4,53%-5,08%-5,13%-47,9%
Shareholders' equity1 -276 361280 568264 862253 720208 118
ROA (Net Profit / Asset) -2,85%3,01%-0,16%0,57%-5,18%
Assets1 -697 376422 9388 212 330-2 294 5291 926 596
Book Value Per Share2 12 40613 14212 21710 63010 7026 429
Cash Flow per Share2 9201 8463 3513 7813 5975 701
Capex1 8 27516 73015 08812 06014 35214 626
Capex / Sales 4,11%3,63%2,99%2,33%2,55%2,61%
Announcement Date 03/16/201703/14/201903/12/202003/18/202103/17/202203/17/2022
1 KRW in Million
2 KRW
Key data
Capitalization (KRW) 1 187 928 675 900
Capitalization (USD) 932 967 357
Net sales (KRW) 560 131 626 310
Net sales (USD) 439 912 373
Number of employees 1 385
Sales / Employee (KRW) 404 427 167
Sales / Employee (USD) 317 626
Free-Float 58,9%
Free-Float capitalization (KRW) 699 678 251 218
Free-Float capitalization (USD) 549 508 554
Avg. Exchange 20 sessions (KRW) 109 741 813 150
Avg. Exchange 20 sessions (USD) 86 188 280
Average Daily Capital Traded 9%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA